5-HT3 RECEPTOR ANTAGONISTS INJECTED INTO THE AREA POSTREMA INHIBIT CISPLATIN-INDUCED EMESIS IN THE FERRET
5-HT3 RECEPTOR ANTAGONISTS INJECTED INTO THE AREA POSTREMA INHIBIT CISPLATIN-INDUCED EMESIS IN THE FERRET
复制标题
DOI:
10.1111/j.1476-5381.1989.tb11948.x
复制
发表时间:
1989-05-01
影响因子:
7.3
通讯作者:
TYERS, MB
中科院分区:
文献类型:
--
作者:
HIGGINS, GA;KILPATRICK, GJ;TYERS, MB
The purpose of the present study was to identify and investigate the role of 5-hydroxytryptamine3 (5-HT3) receptors in the area postrema in the control of cisplatin-induced emesis in the ferret. Homogenate binding and autoradiography experiments using the high affinity 5-HT3 receptor ligand, [3H]-GR65630, identified the presence of a high concentration of 5-HT3 receptors in the area postrema of the ferret. Intraperitonal injection of the 5-HT3 receptor antagonists, GR38032F, GR65630A and MDL72222, at does of 1, 0.1 and 1 mg kg-1 respectively, inhibited emesis induced by cisplatin, 9 mg kg-1 i.p. Discrete injection of low doses of the 5-HT3 receptor antagonists directly into the area postrema region also inhibited cisplatin-induced (9 mg kg-1 i.p.) emesis. The dose ranges used were: GR38032F, 0.01-1 .mu.g; GR65630A, 0.001-0.1 .mu.g; MDL72222, 0.1-10 .mu.g. Cisplatin-induced emesis was not inhibited by discrete injection of ketanserin (30 .mu.g) or methiothepin (30 .mu.gg) into the area postrema. Injection of the 5-HT3 receptor agonist, 2-methyl-5-HT, directly into the area postrema produced an incomplete emetic response. These results confirm a role of 5-HT, and in particular 5-HT3 receptors, in the control of cisplatin-induced emesis, and show that at least one functional site for these receptors in modulating the emetic response is the area postrema, the locus of the chemoreceptor trigger zone.